As Gilead’s HIV, HCV Hull Leaks In Q4, Veklury Plugs Holes

No Signs Of Variant Strain Resistance To Remdesivir

 
• By Alaric DeArment
  
3D Coronavirus cells
Veklury helped Gilead keep its sales in the black during the fourth quarter and full year of 2020. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip